Quest to use Matrix-Bio-developed biomarkers for breast cancer test

04/12/2013 | GenomeWeb Daily News (free registration)

Quest Diagnostics has licensed the rights to biomarkers developed by Matrix-Bio in an effort to create a clinical test for recurrent breast cancer. Matrix-Bio Founder and CSO Dan Raftery called the move "a big step toward our goal to make improved and more efficient testing methods for diagnosing many forms of cancer available to physicians and patients."

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX